Cost implications of the use of ramipril in high-risk patients based on the Heart Outcomes Prevention Evaluation (HOPE) study.

[1]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[2]  A. Gafni,et al.  Outcomes and costs of coronary artery bypass grafting: comparison between octogenarians and septuagenarians at a tertiary care centre. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[3]  J. Pogue,et al.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[4]  J Carpenter,et al.  Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. , 2000, Statistics in medicine.

[5]  G. Francis,et al.  ACE inhibition in cardiovascular disease. , 2000, The New England journal of medicine.

[6]  Jonathan B. Brown,et al.  The progressive cost of complications in type 2 diabetes mellitus. , 1999, Archives of internal medicine.

[7]  A Briggs,et al.  The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation , 1998, Journal of health services research & policy.

[8]  J Lipscomb,et al.  Inpatient costs of specific cerebrovascular events at five academic medical centers. , 1996, Neurology.

[9]  Janzen,et al.  The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. , 1996, The Canadian journal of cardiology.

[10]  S. Yusuf,et al.  Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. , 1994, Circulation.

[11]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[12]  M. Kukin.  Clinical trials report , 2001 .

[13]  A. Fournier,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.